Using the treatment regimen outlined in Fig. 4a, we found that the combination of anti-CSF1R and vaccine elicited significant tumor control compared to the untreated, anti-CSF1R monotherapy and vaccine monotherapy groups (Fig. 4b). Here, CSF1R is linked to neoplasm.